PharmacovigilanceOfficial
CMS proposes Medicare Advantage rule to ease market entry and widen beneficiary choice
🇺🇸 CMS · Fri 20 Nov 2026
The proposed rule would lower administrative barriers for new entrants in Medicare Advantage and Part D, and would be paired with a new CMMI model if finalised.
The US Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule on Medicare Advantage, announced on 20 November 2026. The agency says the aim is to strengthen competition, raise care quality and expand beneficiary choice.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (CMS). AI-assisted; check the source before acting.
More Pharmacovigilance
All →
FDA early alert: Heraeus Medevio recalls vascular guidewires over hydrophilic coating clumping risk
🇺🇸 FDA MedWatch · Fri 20 Nov 2026
EMA publishes PSUSA outcome for ibuprofen medicines, concluding with a variation
🇪🇺 EMA · Fri 20 Nov 2026
EMA publishes PSUSA outcome for nationally authorised split-virion inactivated influenza vaccines, recommending a variation
🇪🇺 EMA · Fri 20 Nov 2026
CMS issues proposed rule on 2028 Medicare Advantage and Part D changes
🇺🇸 CMS · Fri 20 Nov 2026
FDA warns Florida clinical investigator over consent failings in INSTI HIV self-test study
🇺🇸 FDA CBER · Fri 20 Nov 2026
Breckenridge recalls one lot of propranolol ER 60 mg capsules over possible metal contamination
🇺🇸 FDA MedWatch · Fri 20 Nov 2026